BIZENGRI 20 mg/mL
Zenocutuzumab · INJECTION · Partner Therapeutics, Inc.
Bizengri (zenocutuzumab) is a prescription injection given intravenously that is used to treat certain types of cancer. It works by targeting specific proteins on cancer cells to help slow or stop their growth.
Key Facts
- Brand Name
- BIZENGRI
- Generic Name
- Zenocutuzumab
- NDC Code (Product)
71837-1000- Manufacturer
- Partner Therapeutics, Inc.
- Strength
- 20 mg/mL
- Dosage Form
- INJECTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761352
- Marketing Start
- 12/04/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is BIZENGRI used for?
Bizengri (zenocutuzumab) is a prescription injection given intravenously that is used to treat certain types of cancer. It works by targeting specific proteins on cancer cells to help slow or stop their growth.
Is BIZENGRI a controlled substance?
BIZENGRI is not classified as a controlled substance by the DEA.
What is the generic name for BIZENGRI?
The generic name for BIZENGRI is Zenocutuzumab. There are no other listed brand versions of Zenocutuzumab.
What is the NDC code for BIZENGRI 20 mg/mL?
The NDC (National Drug Code) for BIZENGRI 20 mg/mL is 71837-1000, listed by Partner Therapeutics, Inc..
Other BIZENGRI Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)